This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
MORRISVILLE, N.C., March 14, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company plans to report third quarter fiscal year 2011 financial results on Form 10-Q on Monday, March 21, 2011. Oxygen's Chairman and CEO Chris Stern and Chief Financial Officer Michael Jebsen will host a conference call and live webcast to discuss the results on Tuesday, March 22, 2011, at 11 a.m. EDT.
To access the live teleconference dial (866) 578-5784 (U.S. and Canada) or (617) 213-8056 (international.) The participant passcode is 93886225. A live webcast will be available on our web site
A replay of the webcast will be available on the Oxygen website, or by phone for a limited time. To access the replay by phone, call (888) 286-8010 (U.S. and Canada) or (617) 801-6888 (international). The passcode for the replay is 38473378.
About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc. is developing medical and cosmetic products that efficiently deliver oxygen to tissues in the body. The company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte
® that is being formulated for both intravenous and topical delivery. This year, the company launched its DERMACYTE
® line of oxygen-rich skin care products. In addition, the company is focused on perfluorocarbon-based oxygen carriers for use in traumatic brain injury, topical wound healing, dermatology and decompression sickness.
The Oxygen Biotherapeutics, Inc. logo is available at
CONTACT: Ellen Corliss
& Investor Relations